ArticlemedRxiv : the preprint server for health sciences2025
PSA/testosterone ratio as a potential biomarker to identify early progressors of adaptive therapy in metastatic castration sensitive prostate cancer.
Jill A Gallaher et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.